Thomas W. Dubensky
CIK 1635590 · President · last filed 2023-01-05
Thomas W. Dubensky is a President who has filed 28 SEC Form 4 insider transactions across 3 companies since 2015. The most recent filing, for TPST, was dated Nov 2, 2023. Across all open-market trades the lifetime net is −$7.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $15.2K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$15.2K
3
28
-$7.33M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TPST | President | 17,437 | $0.87 | $15.2K | $9.6K | 5 | 2023-01-05 |
| HTG MOLECULAR DIAGNOSTICS, INC (HTGM) Delisted | Director | — | $0.48 | — | $0 | 1 | 2022-08-22 |
| CHINOOK THERAPEUTICS, INC. (ADRO) Delisted | Chief Scientific Officer | 80,812 | — | — | -$7.34M | 21 | 2017-08-11 |
Recent Filings
28 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-11-02 | TPST | Notice (144) | −30,000 | -$131.5K | EDGAR |
| 2023-01-05 | TPST | Grant (A) | — | $0 | EDGAR |
| 2022-08-22 | HTG MOLECULAR DIAGNOSTICS, INC (HTGM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-22 | TPST | Grant (A) | — | $0 | EDGAR |
| 2022-01-11 | TPST | Buy (P) | +2,000 | $9.6K | EDGAR |
| 2022-01-06 | TPST | Grant (A) | — | $0 | EDGAR |
| 2021-06-29 | TPST | Grant (A) | +111,343 | $0 | EDGAR |
| 2017-08-11 | CHINOOK THERAPEUTICS, INC. (ADRO) Delisted | Mixed | — | -$519.2K | EDGAR |
| 2017-07-06 | CHINOOK THERAPEUTICS, INC. (ADRO) Delisted | Mixed | — | -$540.6K | EDGAR |
| 2017-06-14 | CHINOOK THERAPEUTICS, INC. (ADRO) Delisted | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.